Growth hormone releasing peptide | CAS:87616-84-0

We serve Growth hormone releasing peptide CAS:87616-84-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Growth hormone releasing peptide

Chemical Name:Growth hormone releasing peptide
CAS.NO:87616-84-0
Synonyms:Growth hormone releasing peptide
GHRP-6 Acetate
GH-Releasing hexapeptide 6
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1407.0±65.0 °C at 760 mmHg
Molecular Formula C46H56N12O6
Molecular Weight 873.014
Flash Point 804.7±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.664
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:1.Lowers body fat: GHRP-6 administration has the reputation of lowering fat, making it a good option for bodybuilders in their cutting cycles. It is also extremely attractive to those people who are weight conscious and are looking to shed those extra pounds without working hard at the gym.
2.Increase muscle: GHRP-6 administration also has the reputation of facilitating an increase and development in muscles.
3.Increase stamina: Those users who are vouching for the drug claim improvement in stamina levels post the administration of GHRP-6.
4.Is protective and anti-inflammatory: GHRP-6 administration initiates better protection of the muscles and acts as an anti-inflammatory agent which is crucial in the muscle recovery process and synthesis. 



Contact us for information like Growth hormone releasing peptide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,GH-Releasing hexapeptide 6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,GH-Releasing hexapeptide 6 Use and application,Growth hormone releasing peptide technical grade,usp/ep/jp grade.


Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Phenylacetic acid manufacturer The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.3-Methyl-6-nitroindazole supplier DPH and BPHC continue to work closely with the CDC to maintain vigilance during this virus outbreak.2-Methyl-5-nitropyridine vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.